- Profile
- Personal Information
- Publications
Experts in Immunology
Priti Bajpai M.J.M. (MARC) BONTEN Rolee Sharma Douglas Darling Donald Demuth Alba Ruiz de Andrés Javier MartÃnez-Picado Prof. Sarat Kumar Dalai Prof. Sarat Kumar Dalai Julià Blanco Cezmi A. Akdis Dr Joanna Kirman Arianna Calcinotto Dennis W. McGee Liz Hedstrom Daniela Brina Joan Press Neil E. Simister Mausumi Sikdar (Nee Bhakta ) Asmita Das View MoreDidier Saurigny is Clinical Development Director in ImmunoInflammation at GSK. He has nearly 20 years of experience in the pharmaceutical industry, with leadership positions in Novartis, Roche/Genentech, MedImmune and Takeda and roles spanning all phases of clinical development. Didier joined GSK in 2017 from Takeda where he was Clinical lead in Rheumatoid Arthritis. Didier has a broad clinical development background in Immunology in particular Rheumatoid Arthritis and Juvenile Idiopathic Arthritis but also in Oncology, CVGI and Drug Safety.
Didier has a proven track record on delivering successfully complex global (>30 countries in every continent) clinical development program in phase 2a, 2b and 3. He has been instrumental in approvals of a RA compound both in the USA (BLA, sBLA) and Europe (First Approval, Type 2 variation) on the back of successfully led trials. This is a personal account. I am only sharing my opinion and not speaking on behalf of any company.